Bausch + Lomb (BLCO) News Today $17.36 -0.08 (-0.44%) As of 01/17/2025 03:59 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Ellsworth Advisors LLC Takes Position in Bausch + Lomb Co. (NYSE:BLCO)Ellsworth Advisors LLC acquired a new stake in shares of Bausch + Lomb Co. (NYSE:BLCO - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 36,844 shares of the company's stock, valuedJanuary 20 at 6:00 AM | marketbeat.comBausch + Lomb (NYSE:BLCO) Price Target Cut to $24.00 by Analysts at Wells Fargo & CompanyJanuary 18 at 2:36 AM | americanbankingnews.comBausch + Lomb Corporation (BLCO) Receives a Buy from Wells FargoJanuary 16, 2025 | markets.businessinsider.comBausch + Lomb (NYSE:BLCO) Given New $24.00 Price Target at Wells Fargo & CompanyWells Fargo & Company dropped their price objective on shares of Bausch + Lomb from $26.00 to $24.00 and set an "overweight" rating on the stock in a research report on Thursday.January 16, 2025 | marketbeat.comBausch + Lomb launches enVista Aspire monofocal, toric intraocular lenses in EUJanuary 14, 2025 | markets.businessinsider.comBausch + Lomb unit acquires Whitecap Biosciences, terms undisclosedJanuary 14, 2025 | markets.businessinsider.comBausch + Lomb Buys Pharma Company Whitecap BiosciencesJanuary 13, 2025 | marketwatch.comBausch + Lomb Launches enVista Aspire™ Intermediate Optimized Monofocal and Toric Intraocular Lenses in the European UnionJanuary 13, 2025 | finance.yahoo.comBausch + Lomb Bolsters Pipeline with Acquisition of Whitecap BiosciencesJanuary 13, 2025 | finance.yahoo.comIs Bausch + Lomb (BLCO) the Best Medical Stock to Buy Under $20?January 12, 2025 | msn.comWells Fargo Sticks to Its Buy Rating for Bausch + Lomb Corporation (BLCO)January 11, 2025 | markets.businessinsider.comBausch & Lomb: Top 10 Undervalued Healthcare Sector Stocks on TSX (BLCO)January 9, 2025 | theglobeandmail.comS&P 500 Futures Rise in Premarket Trading; Aurora Innovation, Bausch + Lomb LeadJanuary 7, 2025 | marketwatch.comBausch + Lomb and Glaucoma Research Foundation Launch Second Annual "Faces of Glaucoma" Campaign and Fundraising ChallengeJanuary 7, 2025 | finance.yahoo.comBausch + Lomb Co. (NYSE:BLCO) Given Consensus Recommendation of "Hold" by BrokeragesShares of Bausch + Lomb Co. (NYSE:BLCO - Get Free Report) have earned an average rating of "Hold" from the thirteen research firms that are presently covering the company, Marketbeat.com reports. One analyst has rated the stock with a sell recommendation, seven have assigned a hold recommendationJanuary 5, 2025 | marketbeat.comBausch + Lomb price target lowered to $22 from $25 at Evercore ISIJanuary 2, 2025 | markets.businessinsider.comBarclays PLC Invests $5.80 Million in Bausch + Lomb Co. (NYSE:BLCO)Barclays PLC bought a new stake in shares of Bausch + Lomb Co. (NYSE:BLCO - Free Report) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 300,500 shares of the company's stock, valued at approximately $5,797,000. BarclaysDecember 21, 2024 | marketbeat.comY Intercept Hong Kong Ltd Takes $555,000 Position in Bausch + Lomb Co. (NYSE:BLCO)Y Intercept Hong Kong Ltd acquired a new position in shares of Bausch + Lomb Co. (NYSE:BLCO - Free Report) in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund acquired 28,791 shares of the company's stock, valued at approximately $555,000.December 16, 2024 | marketbeat.comShort Interest in Bausch + Lomb Co. (NYSE:BLCO) Increases By 11.7%Bausch + Lomb Co. (NYSE:BLCO - Get Free Report) was the target of a large increase in short interest in November. As of November 30th, there was short interest totalling 1,080,000 shares, an increase of 11.7% from the November 15th total of 967,300 shares. Based on an average trading volume of 648,800 shares, the short-interest ratio is currently 1.7 days. Approximately 3.1% of the company's stock are sold short.December 15, 2024 | marketbeat.comBofA rates Bausch & Lomb ‘underperform’ with lower buyout chancesDecember 14, 2024 | msn.com49,633 Shares in Bausch + Lomb Co. (NYSE:BLCO) Purchased by Janus Henderson Group PLCJanus Henderson Group PLC purchased a new stake in Bausch + Lomb Co. (NYSE:BLCO - Free Report) during the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 49,633 shares of the company's stock, valued at approximately $957,000.December 14, 2024 | marketbeat.comBausch + Lomb responds to rumors of potential saleDecember 13, 2024 | markets.businessinsider.comBausch + Lomb Responds to Rumors of a Potential SaleDecember 13, 2024 | businesswire.comBausch + Lomb confirms board mulling sale of the company that would separate it from parentDecember 12, 2024 | marketwatch.comBausch + Lomb Confirms It Is Exploring a Potential SaleDecember 12, 2024 | bloomberg.comBausch + Lomb Corporation (BLCO) Has a New Rating from Bank of America SecuritiesDecember 12, 2024 | markets.businessinsider.comBausch & Lomb edges higher after confirming sales processDecember 12, 2024 | msn.comBausch + Lomb's (BLCO) "Buy" Rating Reiterated at HC WainwrightHC Wainwright reiterated a "buy" rating and issued a $23.00 price target on shares of Bausch + Lomb in a report on Thursday.December 12, 2024 | marketbeat.comBausch + Lomb Shares Down on Report That Potential Buyer May Back OutDecember 12, 2024 | marketwatch.comBausch + Lomb falls -12.7%December 12, 2024 | markets.businessinsider.comCitigroup Downgrades Bausch + Lomb (BLCO)December 12, 2024 | msn.comBausch + Lomb übernimmt Innovator für Glaukom-ChirurgieDecember 11, 2024 | de.investing.comBausch + Lomb Acquires Elios Vision, Significantly Enhances Glaucoma Treatment CapabilitiesDecember 11, 2024 | finance.yahoo.comWall Street Breakfast Podcast: GM Pumps The Brakes On RobotaxisDecember 11, 2024 | seekingalpha.comBausch + Lomb down after report that Blackstone could back away from takeover bidDecember 11, 2024 | msn.comKing Street Capital Management L.P. Buys New Stake in Bausch + Lomb Co. (NYSE:BLCO)King Street Capital Management L.P. purchased a new stake in shares of Bausch + Lomb Co. (NYSE:BLCO - Free Report) during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 732,065 shares ofDecember 11, 2024 | marketbeat.comBausch + Lomb (NYSE:BLCO) Downgraded by Citigroup to "Neutral"Citigroup lowered shares of Bausch + Lomb from a "buy" rating to a "neutral" rating and reduced their price objective for the company from $24.00 to $22.00 in a research report on Wednesday.December 11, 2024 | marketbeat.comBausch + Lomb Co. (NYSE:BLCO) Given Consensus Rating of "Moderate Buy" by AnalystsBausch + Lomb Co. (NYSE:BLCO - Get Free Report) has been given an average rating of "Moderate Buy" by the twelve analysts that are currently covering the firm, MarketBeat Ratings reports. Six analysts have rated the stock with a hold rating and six have given a buy rating to the company. The averaDecember 11, 2024 | marketbeat.comQuadrature Capital Ltd Invests $526,000 in Bausch + Lomb Co. (NYSE:BLCO)Quadrature Capital Ltd acquired a new stake in Bausch + Lomb Co. (NYSE:BLCO - Free Report) during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 27,317 shares of the company's stock, valued at approxiDecember 9, 2024 | marketbeat.comWells Fargo Sticks to Their Buy Rating for Bausch + Lomb Corporation (BLCO)December 8, 2024 | markets.businessinsider.comBausch + Lomb Co. (NYSE:BLCO) Shares Sold by Walleye Capital LLCWalleye Capital LLC lessened its holdings in shares of Bausch + Lomb Co. (NYSE:BLCO - Free Report) by 65.8% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 32,780 shares of the company's stock after selling 63,070 sDecember 8, 2024 | marketbeat.comWhitebox Advisors LLC Reduces Stake in Bausch + Lomb Co. (NYSE:BLCO)Whitebox Advisors LLC lowered its stake in shares of Bausch + Lomb Co. (NYSE:BLCO - Free Report) by 19.6% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 1,243,245 shares of the company's stock after selling 30December 6, 2024 | marketbeat.comMaple Rock Capital Partners Inc. Has $69.78 Million Holdings in Bausch + Lomb Co. (NYSE:BLCO)Maple Rock Capital Partners Inc. cut its holdings in Bausch + Lomb Co. (NYSE:BLCO - Free Report) by 3.4% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 3,617,548 shares of the company's stDecember 4, 2024 | marketbeat.comCinctive Capital Management LP Invests $870,000 in Bausch + Lomb Co. (NYSE:BLCO)Cinctive Capital Management LP purchased a new stake in Bausch + Lomb Co. (NYSE:BLCO - Free Report) during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm purchased 45,102 shares of the company's stock, valued at approximately $870,000. Other inDecember 4, 2024 | marketbeat.comMorgan Stanley Downgrades Bausch + Lomb (BLCO)December 2, 2024 | msn.comBausch + Lomb downgraded to Equal Weight from Overweight at Morgan StanleyDecember 2, 2024 | markets.businessinsider.comMorgan Stanley stuft Bausch & Lomb auf Equalweight herab, nachdem Aktie im vergangenen Jahr um 30% gestiegen istDecember 2, 2024 | de.investing.comBausch + Lomb (NYSE:BLCO) Downgraded by Morgan Stanley to Equal WeightMorgan Stanley downgraded shares of Bausch + Lomb from an "overweight" rating to an "equal weight" rating and set a $19.00 price objective on the stock. in a research note on Monday.December 2, 2024 | marketbeat.comBausch + Lomb Co. (NYSE:BLCO) Short Interest Down 13.6% in NovemberBausch + Lomb Co. (NYSE:BLCO - Get Free Report) was the target of a large decline in short interest during the month of November. As of November 15th, there was short interest totalling 967,300 shares, a decline of 13.6% from the October 31st total of 1,120,000 shares. Based on an average daily trading volume, of 639,700 shares, the days-to-cover ratio is currently 1.5 days. Currently, 2.5% of the shares of the company are short sold.December 1, 2024 | marketbeat.comGoldentree Asset Management LP Sells 1,745,693 Shares of Bausch + Lomb Co. (NYSE:BLCO)Goldentree Asset Management LP decreased its holdings in shares of Bausch + Lomb Co. (NYSE:BLCO - Free Report) by 34.2% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 3,355,437 shares of the company's stock after sellingNovember 29, 2024 | marketbeat.com Get Bausch + Lomb News Delivered to You Automatically Sign up to receive the latest news and ratings for BLCO and its competitors with MarketBeat's FREE daily newsletter. Email Address BLCO Media Mentions By Week BLCO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BLCO News Sentiment▼0.230.44▲Average Medical News Sentiment BLCO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BLCO Articles This Week▼75▲BLCO Articles Average Week Get Bausch + Lomb News Delivered to You Automatically Sign up to receive the latest news and ratings for BLCO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Koninklijke Philips News Today Zimmer Biomet News Today Solventum News Today Smith & Nephew News Today Penumbra News Today Glaukos News Today Stevanato Group News Today Inspire Medical Systems News Today Inari Medical News Today PROCEPT BioRobotics News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:BLCO) was last updated on 1/20/2025 by MarketBeat.com Staff From Our PartnersBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredWarren Buffett Bets $40 Billion—You Can Get in for $20I call it "The Last Retirement Stock You'll Ever Need." Warren Buffett himself owns $40 billion of stock in...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredTrump’s Inauguration Shocker: “Move Your Cash Now”Just in the first week after Trump's win, many stocks jumped by double and even triple digits. But now he's...InvestorPlace | Sponsoredliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bausch + Lomb Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bausch + Lomb With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BLCO Stock Alerts